JP2022548464A5 - - Google Patents

Info

Publication number
JP2022548464A5
JP2022548464A5 JP2022501255A JP2022501255A JP2022548464A5 JP 2022548464 A5 JP2022548464 A5 JP 2022548464A5 JP 2022501255 A JP2022501255 A JP 2022501255A JP 2022501255 A JP2022501255 A JP 2022501255A JP 2022548464 A5 JP2022548464 A5 JP 2022548464A5
Authority
JP
Japan
Prior art keywords
article
steroid
substance
implant
steroid substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022501255A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022548464A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/000663 external-priority patent/WO2021005417A1/en
Publication of JP2022548464A publication Critical patent/JP2022548464A/ja
Publication of JP2022548464A5 publication Critical patent/JP2022548464A5/ja
Pending legal-status Critical Current

Links

JP2022501255A 2019-07-10 2020-07-09 二量体ステロイドプロドラッグを含む表面コーティングおよび埋込み可能なデバイス、およびその使用 Pending JP2022548464A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962872506P 2019-07-10 2019-07-10
US62/872,506 2019-07-10
US201962880737P 2019-07-31 2019-07-31
US62/880,737 2019-07-31
PCT/IB2020/000663 WO2021005417A1 (en) 2019-07-10 2020-07-09 Surface coatings and implantable devices comprising dimeric steroid prodrugs, and uses thereof

Publications (2)

Publication Number Publication Date
JP2022548464A JP2022548464A (ja) 2022-11-21
JP2022548464A5 true JP2022548464A5 (cg-RX-API-DMAC7.html) 2023-07-19

Family

ID=74114966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022501255A Pending JP2022548464A (ja) 2019-07-10 2020-07-09 二量体ステロイドプロドラッグを含む表面コーティングおよび埋込み可能なデバイス、およびその使用

Country Status (5)

Country Link
US (1) US20220288277A1 (cg-RX-API-DMAC7.html)
EP (1) EP3996764A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022548464A (cg-RX-API-DMAC7.html)
CN (1) CN114599406A (cg-RX-API-DMAC7.html)
WO (1) WO2021005417A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3740494A4 (en) 2018-02-02 2021-11-03 Ripple Therapeutics Corporation GLASS FORMULATIONS WITH STEROID DIMERS AND USES THEREOF
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
US12509469B2 (en) 2019-08-07 2025-12-30 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependence disorders
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
MX2023000870A (es) 2020-07-21 2023-05-19 Chembeau LLC Formulaciones cosmeticas de diester y usos de las mismas.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8907883A (pt) * 1989-03-09 1991-12-24 Endocon Inc Pelota de peptideo parcialmente fundida e seu processo de fabricacao
PT740650E (pt) * 1994-01-28 2004-10-29 Univ Kentucky Res Found Co-farmacos como um metodo de administracao controlada de farmacos
EP0874643B1 (en) * 1996-02-15 2001-11-21 J. Paul Santerre Bioresponsive pharmacologically-active polymers and articles made therefrom
US20030158598A1 (en) * 2001-09-17 2003-08-21 Control Delivery Systems, Inc. System for sustained-release delivery of anti-inflammatory agents from a coated medical device
US20030118528A1 (en) * 2001-11-19 2003-06-26 Walters Kenneth A. Topical delivery of codrugs
US20050164994A1 (en) * 2001-12-10 2005-07-28 Control Deliver Systems, Inc. Treatment of genitourinary tract disorders
WO2004037843A2 (en) * 2002-10-25 2004-05-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
WO2005009480A2 (en) * 2003-06-11 2005-02-03 Control Delivery Systems, Inc. Implants containing codrugs
US8147865B2 (en) * 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US9205241B2 (en) * 2011-07-12 2015-12-08 Warsaw Orthopedic, Inc. Medical devices and methods comprising an adhesive material
EP2968698B1 (en) * 2013-03-15 2018-01-10 Interface Biologics Inc. Coating for drug release
EP3740494A4 (en) * 2018-02-02 2021-11-03 Ripple Therapeutics Corporation GLASS FORMULATIONS WITH STEROID DIMERS AND USES THEREOF

Similar Documents

Publication Publication Date Title
JP2023058591A (ja) 組成物
CN107072955A (zh) 包含多肽和/或蛋白质的固体块的药物组合物和该固体块的制备方法
AR075148A1 (es) Formulacion de rasagilina de liberacion retardada. proceso para fabricar citrato de rasagilina
JP2023501375A5 (cg-RX-API-DMAC7.html)
JP2011504484A (ja) 膣内薬剤放出システム
JP2021519076A5 (cg-RX-API-DMAC7.html)
JP2019031567A5 (cg-RX-API-DMAC7.html)
JP2016065094A5 (cg-RX-API-DMAC7.html)
RU2010115785A (ru) Система доставки лекарственных веществ
JP2008508279A5 (cg-RX-API-DMAC7.html)
JP2006500344A5 (ja) 複合遅延放出抗生物質製剤、その使用及びその作成方法
JPWO2020250915A5 (cg-RX-API-DMAC7.html)
JP2006265245A5 (cg-RX-API-DMAC7.html)
NZ587897A (en) Drug delivery systems comprising weakly basic drugs and organic acids
JP2022541341A5 (cg-RX-API-DMAC7.html)
JP2011503075A5 (cg-RX-API-DMAC7.html)
AU2013220139B2 (en) Hydrocortisone controlled release formulation
JP2008543936A5 (cg-RX-API-DMAC7.html)
JP2009529554A5 (cg-RX-API-DMAC7.html)
JP2025072466A5 (cg-RX-API-DMAC7.html)
JP2012533595A5 (cg-RX-API-DMAC7.html)
JP2017519762A5 (cg-RX-API-DMAC7.html)
JP2008501741A6 (ja) 多層制御放出性メチルフェニデートペレット
JP2008501741A (ja) 多層制御放出性メチルフェニデートペレット
JP2022501332A5 (cg-RX-API-DMAC7.html)